1. Home
  2. WRB vs NTRA Comparison

WRB vs NTRA Comparison

Compare WRB & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W.R. Berkley Corporation

WRB

W.R. Berkley Corporation

HOLD

Current Price

$66.26

Market Cap

25.7B

Sector

Finance

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$221.22

Market Cap

29.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRB
NTRA
Founded
1967
2003
Country
United States
United States
Employees
8804
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.7B
29.1B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
WRB
NTRA
Price
$66.26
$221.22
Analyst Decision
Hold
Strong Buy
Analyst Count
16
15
Target Price
$68.86
$259.07
AVG Volume (30 Days)
1.8M
1.6M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
2.78%
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
N/A
$210,939,000.00
Revenue This Year
$5.18
$18.08
Revenue Next Year
$4.95
$19.65
P/E Ratio
$15.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$62.87
$131.81
52 Week High
$78.96
$256.36

Technical Indicators

Market Signals
Indicator
WRB
NTRA
Relative Strength Index (RSI) 50.52 59.48
Support Level $64.85 $186.96
Resistance Level $68.91 $244.65
Average True Range (ATR) 1.38 10.42
MACD -0.12 1.93
Stochastic Oscillator 54.46 84.27

Price Performance

Historical Comparison
WRB
NTRA

About WRB W.R. Berkley Corporation

W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: